We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBK:JSEStandard Bank Group Limited Analysis

Data as of 2026-06-27 - not real-time

ZAC 31,808.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Standard Bank Group (SBK) is trading just above its 20‑day SMA at 31,808 ZAc, confirming a bullish bias while the 50‑day and 200‑day SMAs remain well below the current level, underscoring a sustained uptrend. The RSI sits at 49, indicating a neutral momentum environment, and the MACD histogram is marginally negative, suggesting a short‑term bearish pressure that has not yet overridden the broader bullish trend. Volume is on the rise, supporting the price move, while 30‑day volatility of roughly 25% is moderate for a financial stock. With a beta of just 0.27, SBK exhibits low market‑risk sensitivity, making it a defensive play within the regional banking sector. Valuation metrics signal a clear discount: the trailing PE of 10.6 is well below the industry average of 16.9, and the forward PE of 8.8 further emphasizes the upside potential. The price‑to‑book ratio of 1.8 and a target median price of 34,125 ZAc imply an upside of about 8% from current levels. Dividend sustainability is strong, highlighted by a 5.36% yield and a payout ratio near 53%, comfortably supported by an operating margin of 43% and ROE of 18.7%. Recent analyst updates have retained a “buy” consensus, reinforcing confidence in the stock’s upside trajectory.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance at 33,900 ZAc
  • Slightly bearish MACD histogram
  • Increasing volume supporting current levels

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to industry PE
  • Strong dividend yield and sustainable payout
  • Revenue growth of ~9% and robust operating margins

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and defensive profile
  • Consistent earnings and attractive dividend
  • Solid capital base despite temporary cash‑flow weakness

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin28.38%
P/E Ratio10.6
ROE18.73%
ROA1.64%
P/B Ratio1.8
Op. Cash FlowZAC-225887993856
Industry P/E16.9

Technical Analysis

TrendBullish
RSI49.3
SupportZAC 30,354.00
ResistanceZAC 33,900.00
MA 20ZAC 31,795.40
MA 50ZAC 31,487.72
MA 200ZAC 28,970.95
MACDBearish
VolumeIncreasing
Fear & Greed Index88.55

Valuation

Target PriceZAC 34,655.70
Upside/Downside8.95%
GradeUndervalued
TypeBlend
Dividend Yield5.36%

Risk Assessment

Beta0.27
Volatility24.77%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.